AR034372A1 - Composiciones farmaceuticas - Google Patents

Composiciones farmaceuticas

Info

Publication number
AR034372A1
AR034372A1 ARP020102107A ARP020102107A AR034372A1 AR 034372 A1 AR034372 A1 AR 034372A1 AR P020102107 A ARP020102107 A AR P020102107A AR P020102107 A ARP020102107 A AR P020102107A AR 034372 A1 AR034372 A1 AR 034372A1
Authority
AR
Argentina
Prior art keywords
pharmaceutical compositions
chitosan
once
ketotifen
eye
Prior art date
Application number
ARP020102107A
Other languages
English (en)
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of AR034372A1 publication Critical patent/AR034372A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)

Abstract

Se da a conocer una composición de fármaco oftálmico de una vez al día, en particular cetotifeno, que comprende un polímero que comprende quitosano y un vehículo, y un método para tratar una alergia ocular, el cual comprende administrar una composición oftálmica de cetotifeno de una vez al día que comprende quitosano, al ojo de un mamífero.
ARP020102107A 2001-06-08 2002-06-06 Composiciones farmaceuticas AR034372A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US29706801P 2001-06-08 2001-06-08

Publications (1)

Publication Number Publication Date
AR034372A1 true AR034372A1 (es) 2004-02-18

Family

ID=23144721

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP020102107A AR034372A1 (es) 2001-06-08 2002-06-06 Composiciones farmaceuticas

Country Status (4)

Country Link
US (1) US20030031718A1 (es)
AR (1) AR034372A1 (es)
PE (1) PE20030064A1 (es)
WO (1) WO2002100376A1 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002100436A2 (en) * 2001-06-08 2002-12-19 Novartis Ag Ophthalmic once-a-day composition
ES2377118T3 (es) 2004-09-21 2012-03-22 Trobio Ab Composición de proteasa estabilizada que comprende una serina proteasa, derivados de morfolino e inhibidores inversos de dicha serina proteasa
JP4980226B2 (ja) * 2004-10-25 2012-07-18 ボーシュ アンド ローム インコーポレイティド 眼科用組成物及びその使用方法
US20060089384A1 (en) * 2004-10-25 2006-04-27 Minno George E Ophthalmic compositions and methods of using the same
US20070208058A1 (en) * 2004-10-25 2007-09-06 Bryant Roy W Stable Pharmaceutical Compositions and Methods of Making and Using Same
US20070077302A1 (en) * 2005-09-30 2007-04-05 Azaam Alli Methods for stabilizing ophthalmic compositions
US20070077303A1 (en) * 2005-09-30 2007-04-05 Azaam Alli Methods for providing oxidatively stable ophthalmic compositions
US20090092574A1 (en) * 2006-12-29 2009-04-09 Scott Richard W Ophthalmic And Otic Compositions Of Facially Amphiphilic Polymers And Oligomers And Uses Thereof
US20090005362A1 (en) * 2007-06-26 2009-01-01 Vo Toan P Compositions Comprising Antihistamines or Mast Cell Stabilizers, and Methods of Making and Using Same
TWI520951B (zh) 2011-05-16 2016-02-11 塞爾西優蒂克斯公司 用於治療粘膜炎的化合物
WO2014150899A1 (en) * 2013-03-15 2014-09-25 Chapin Matthew J Topical ophthalmic formulations for treating migraine
US11771694B2 (en) 2020-06-05 2023-10-03 Innovation Pharmaceuticals Inc. Arylamide compounds for treatment and prevention of viral infections

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5422116A (en) * 1994-02-18 1995-06-06 Ciba-Geigy Corporation Liquid ophthalmic sustained release delivery system
TW389694B (en) * 1995-08-17 2000-05-11 Novartis Ag Compositions including o-carboxyalkyl chitosan and methods of use in ophthalmics
EP0938896A1 (en) * 1998-01-15 1999-09-01 Novartis AG Autoclavable pharmaceutical compositions containing a chelating agent
US6777429B1 (en) * 1999-07-23 2004-08-17 Novartis Ag Ophthalmic composition

Also Published As

Publication number Publication date
US20030031718A1 (en) 2003-02-13
PE20030064A1 (es) 2003-03-18
WO2002100376A1 (en) 2002-12-19

Similar Documents

Publication Publication Date Title
CY1114048T1 (el) Συνδυασμος βριμονιδινης και τιμολολης για τοπικη οφθαλμικη χρηση
AR034372A1 (es) Composiciones farmaceuticas
AR034371A1 (es) Composiciones farmaceuticas
WO2007002572A3 (en) Nattokinase for reducing whole blood viscosity
HUP0401568A2 (hu) Periokuláris vagy subconjunctivális adagolásra alkalmas szemészeti depó készítmények
NI200800261A (es) Tratamientos de alergia ocular
NO2013016I2 (no) Okriplasmin
ATE478656T1 (de) Biologisch abbaubare polymerzusammensetzungen, zusammensetzungen und damit in beziehung stehende verwendungen
AR049985A1 (es) Tratamiento de combinacion para enfermedades malignas no hematologicas
TWI366471B (en) Compositions and methods for localized therapy of the eye
BRPI0513424A (pt) tratamento de pele com luz e agente de benefìcio
ECSP056159A (es) Composición de fármaco conjugado
MX2009005644A (es) Gel util para el suministro de farmacos oftalmicos.
DK1576970T3 (da) Intraluminal indretning med en coating, der indeholder et terapeutisk middel
MX2007004775A (es) Tratamiento de presbiopia por alteracion del lente.
DE602007013391D1 (de) Cyclosporins zur behandlung und vorbeugung von augenerkrankungen
WO2004069181A3 (en) Composition for the treatment of intraocular pressure
CL2010001406A1 (es) Composicion farmaceutica oftalmica que comprende povidona yodada, y un compuesto antiinflamatorio esteroidal, un compuesto antiinflamatorio no esteroidal, un antibacteriano, un antialergico o un compuesto antiglaucoma; y metodo para preservar la composicion.
AR047205A1 (es) Composiciones oftalmicas que contienen una combinacion sinergica de tres polimeros
CY1116938T1 (el) Αναπληρωτικη θεραπεια της ασθενειας huntington και αλλων ασθενειων πολυγλουταμiνης
EP4279063A3 (en) Ophthalmic pharmaceutical composition, preparation method therefor and application thereof
AU2010279892A8 (en) Humanized anti-amyloid-b oligomer antibody
EP1808158A3 (en) Presbyopia treatment by lens alteration
BRPI0611526A2 (pt) composição tópica contendo gelatina
BRPI0414518A (pt) composições farmacêuticas e métodos compreendendo combinações de derivados de 2-alquilideno-19-nor-vitamina d e hormÈnio paratireoidiano

Legal Events

Date Code Title Description
FB Suspension of granting procedure